Found: 38
Select item for more details and to access through your institution.
HMGB1/RAGE induces IL-17 expression to exaggerate inflammation in peripheral blood cells of hepatitis B patients.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Development of a nomogram to assess thromboembolic risk in patients with liver abscesses.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-77799-4
- By:
- Publication type:
- Article
An Early Increase in IL-10 and TNF-α Levels Following Atezolizumab Plus Bevacizumab Treatment Predicts Survival in Advanced Hepatocellular Carcinoma Patients: A Prospective Cohort Study.
- Published in:
- Cancers, 2024, v. 16, n. 20, p. 3543, doi. 10.3390/cancers16203543
- By:
- Publication type:
- Article
An Immunological Perspective on the Mechanism of Drug Induced Liver Injury: Focused on Drugs for Treatment of Hepatocellular Carcinoma and Liver Transplantation.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 5, p. 5002, doi. 10.3390/ijms24055002
- By:
- Publication type:
- Article
Immunological Markers, Prognostic Factors and Challenges Following Curative Treatments for Hepatocellular Carcinoma.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 19, p. 10271, doi. 10.3390/ijms221910271
- By:
- Publication type:
- Article
Distinct Patterns of HBV Integration and TERT Alterations between in Tumor and Non-Tumor Tissue in Patients with Hepatocellular Carcinoma.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 13, p. 7056, doi. 10.3390/ijms22137056
- By:
- Publication type:
- Article
Preferential Expression of Programmed Death Ligand 1 Protein in Tumor-Associated Macrophages and Its Potential Role in Immunotherapy for Hepatocellular Carcinoma.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 9, p. 4710, doi. 10.3390/ijms22094710
- By:
- Publication type:
- Article
A Real-World Comparative Analysis of Lenvatinib and Sorafenib as a Salvage Therapy for Transarterial Treatments in Unresectable HCC.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 12, p. 4121, doi. 10.3390/jcm9124121
- By:
- Publication type:
- Article
Differential liver function at cessation of atezolizumabbevacizumab versus lenvatinib in HCC: a multicenter, propensity-score matched comparative study.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1372007
- By:
- Publication type:
- Article
Patient-Derived Avatar Mouse Model to Predict the Liver Immune Homeostasis of Long-Term Stable Liver Transplant Patients.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.817006
- By:
- Publication type:
- Article
FK506 and Lactobacillus acidophilus ameliorate acute graft-versus-host disease by modulating the T helper 17/regulatory T-cell balance.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Machine learning-based clinical decision support system for treatment recommendation and overall survival prediction of hepatocellular carcinoma: a multi-center study.
- Published in:
- NPJ Digital Medicine, 2024, v. 7, n. 1, p. 1, doi. 10.1038/s41746-023-00976-8
- By:
- Publication type:
- Article
Real-Life Experience of mTOR Inhibitors in Liver Transplant Recipients in a Region Where Living Donation Is Predominant.
- Published in:
- Frontiers in Pharmacology, 2021, v. 12, p. 1, doi. 10.3389/fphar.2021.685176
- By:
- Publication type:
- Article
A Real-World Comparative Study of Microwave and Radiofrequency Ablation in Treatment-Naïve and Recurrent Hepatocellular Carcinoma.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 2, p. 302, doi. 10.3390/jcm11020302
- By:
- Publication type:
- Article
Comparative Analysis of Lenvatinib and Hepatic Arterial Infusion Chemotherapy in Unresectable Hepatocellular Carcinoma: A Multi-Center, Propensity Score Study.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 18, p. 4045, doi. 10.3390/jcm10184045
- By:
- Publication type:
- Article
A Real-World Comparative Analysis of Atezolizumab Plus Bevacizumab and Transarterial Chemoembolization Plus Radiotherapy in Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombosis.
- Published in:
- Cancers, 2023, v. 15, n. 17, p. 4423, doi. 10.3390/cancers15174423
- By:
- Publication type:
- Article
Significance of TERT Genetic Alterations and Telomere Length in Hepatocellular Carcinoma.
- Published in:
- Cancers, 2021, v. 13, n. 9, p. 2160, doi. 10.3390/cancers13092160
- By:
- Publication type:
- Article
Differential HBV replicative markers and covalently closed circular DNA transcription in immune‐active chronic hepatitis B with and without HBeAg.
- Published in:
- Liver International, 2024, v. 44, n. 10, p. 2753, doi. 10.1111/liv.16032
- By:
- Publication type:
- Article
Sustained off therapy response after peglyated interferon favours functional cure and no disease progression in chronic hepatitis B.
- Published in:
- Liver International, 2021, v. 41, n. 2, p. 288, doi. 10.1111/liv.14701
- By:
- Publication type:
- Article
Analysis of Immune-Related Adverse Events of Atezolizumab and Bevacizumab in Patients with Hepatocellular Carcinoma: A Multicentre Cohort Study.
- Published in:
- Liver Cancer (2235-1795), 2024, v. 13, n. 4, p. 413, doi. 10.1159/000535839
- By:
- Publication type:
- Article
HBeAg-positive grey-zone patients: Treatment be- yond guideline recommendations?
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 3, p. 825, doi. 10.3350/cmh.2023.0185
- By:
- Publication type:
- Article
Autoimmune liver disease represented as primary biliary cholangitis after SARS-CoV-2 infection: A need for population-based cohort study.
- Published in:
- Clinical & Molecular Hepatology, 2022, v. 28, n. 4, p. 926, doi. 10.3350/cmh.2022.0233
- By:
- Publication type:
- Article
Clinical characteristics of portal hypertension complicated by gastroesophageal varices in patients with myeloproliferative neoplasms.
- Published in:
- Clinical & Molecular Hepatology, 2020, v. 26, n. 1, p. 78, doi. 10.3350/cmh.2019.0078
- By:
- Publication type:
- Article
Cardiac diastolic dysfunction predicts poor prognosis in patients with decompensated liver cirrhosis.
- Published in:
- Clinical & Molecular Hepatology, 2018, v. 24, n. 4, p. 409, doi. 10.3350/cmh.2018.0034
- By:
- Publication type:
- Article
A comparative study of sorafenib and metronomic chemotherapy for Barcelona Clinic Liver Cancer-stage C hepatocellular carcinoma with poor liver function.
- Published in:
- Clinical & Molecular Hepatology, 2017, v. 23, n. 2, p. 128, doi. 10.3350/cmh.2016.0071
- By:
- Publication type:
- Article
Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in virologically suppressed patient with chronic hepatitis B.
- Published in:
- Journal of Gastroenterology & Hepatology, 2024, v. 39, n. 8, p. 1673, doi. 10.1111/jgh.16593
- By:
- Publication type:
- Article
Use of M2BPGi in HCC patients with TACE.
- Published in:
- Journal of Gastroenterology & Hepatology, 2021, v. 36, n. 10, p. 2917, doi. 10.1111/jgh.15553
- By:
- Publication type:
- Article
Combination Treatment With Metformin and Tacrolimus Improves Systemic Immune Cellular Homeostasis by Modulating Treg and Th17 Imbalance.
- Published in:
- Frontiers in Immunology, 2021, v. 11, p. N.PAG, doi. 10.3389/fimmu.2020.581728
- By:
- Publication type:
- Article
Reactivation of Resolved Hepatitis B After Daratumumab for Multiple Myeloma.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 6, p. e1372, doi. 10.1093/cid/ciab302
- By:
- Publication type:
- Article
Effect of Biliary Drainage on the Prognosis of Patients with Hepatocellular Carcinoma and Bile Duct Invasion.
- Published in:
- Gut & Liver, 2024, v. 18, n. 5, p. 877, doi. 10.5009/gnl240032
- By:
- Publication type:
- Article
Serum Level of Growth Differentiation Factor 15 Reflects the Aggressiveness of Hepatocellular Carcinoma Including Metastasis.
- Published in:
- Gut & Liver, 2019, v. 13, n. 6(suppl. 1), p. 110
- By:
- Publication type:
- Article
Sustained Response without Nucleos(t)ides after Pegylated Interferon Represent Favorable Outcome: Up to 13 Years Follow-up.
- Published in:
- Gut & Liver, 2019, v. 13, n. 6(suppl. 1), p. 106
- By:
- Publication type:
- Article
The Impact of Histologic Portal T-Cell Density on the Clinical Outcomes in Hepatic Graft-versus-Host Disease and Autoimmune Liver Diseases.
- Published in:
- Diagnostics (2075-4418), 2024, v. 14, n. 16, p. 1745, doi. 10.3390/diagnostics14161745
- By:
- Publication type:
- Article
Long-Term HBsAg Titer Kinetics with Entecavir/Tenofovir: Implications for Predicting Functional Cure and Low Levels.
- Published in:
- Diagnostics (2075-4418), 2024, v. 14, n. 5, p. 495, doi. 10.3390/diagnostics14050495
- By:
- Publication type:
- Article
Nutritional standards for energy-dense low-nutrient density foods for children in Korea.
- Published in:
- Asia Pacific Journal of Clinical Nutrition, 2014, v. 23, n. 1, p. 27, doi. 10.6133/apjcn.2014.23.1.03
- By:
- Publication type:
- Article
Comparing various scoring system for predicting overall survival according to treatment modalities in hepatocellular carcinoma focused on Platelet-albumin-bilirubin (PALBI) and albumin-bilirubin (ALBI) grade: A nationwide cohort study.
- Published in:
- PLoS ONE, 2019, v. 14, n. 5, p. 1, doi. 10.1371/journal.pone.0216173
- By:
- Publication type:
- Article
Diffusion-Weighted Magnetic Resonance Imaging in Hepatocellular Carcinoma as a Predictor of a Response to Cisplatin-Based Hepatic Arterial Infusion Chemotherapy.
- Published in:
- Frontiers in Oncology, 2020, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.600233
- By:
- Publication type:
- Article
Real-World Outcomes of Nivolumab in Patients With Unresectable Hepatocellular Carcinoma in an Endemic Area of Hepatitis B Virus Infection.
- Published in:
- Frontiers in Oncology, 2020, p. 1, doi. 10.3389/fonc.2020.01043
- By:
- Publication type:
- Article